NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Relapsed and/or refractory acute lymphoblastic (ALL) or myeloid (AML) leukemia in patients who are not eligible for curative therapies and lack other available therapeutic options
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.